uniQure (QURE) Long-Term Investments (2022 - 2026)
uniQure (QURE) posted quarterly Long-Term Investments of $30.3 million for Q2 2026, up 1.79% year-over-year from $29.7 million in Q2 2025, and little changed quarter-over-quarter from $30.2 million in Q1 2026.
Analysis
uniQure (QURE) Long-Term Investments (2022 - 2026) Analysis & Trends
uniQure's Long-Term Investments history runs 5 years deep, the most recent figure standing at $30.3 million for Q2 2026.
- In Q2 2026, Long-Term Investments rose 1.79% year-over-year to $30.3 million; the TTM figure through Jun 2026 stood at $30.3 million (up 1.79% YoY), while the FY2025 annual figure was $30.2 million, up 10.1% from the prior year.
- Long-Term Investments for Q2 2026 stood at $30.3 million, roughly flat from $30.2 million in the prior quarter.
- The five-year high for Long-Term Investments was $40.0 million in Q4 2022, with the low at $2.2 million in Q4 2023.
- The 5-year median for Long-Term Investments is $29.9 million (2025), against an average of $27.7 million.
- The sharpest annual moves came in 2023 and 2024: Long-Term Investments sank 94.55% in 2023, then jumped 1160.39% in 2024.
- uniQure's Long-Term Investments stood at $40.0 million in 2022, then tumbled by 94.55% to $2.2 million in 2023, then surged by 1160.39% to $27.5 million in 2024, then rose by 10.1% to $30.2 million in 2025, then increased by 0.1% to $30.3 million in 2026.
- Business Quant data shows QURE's Long-Term Investments at $30.3 million in Q2 2026, $30.2 million in Q1 2026, and $30.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -4.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1.77 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 372.10 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 30.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.27 Mn |
| Mar 31, 2026 | 30.15 Mn |
| Dec 31, 2025 | 30.24 Mn |
| Sep 30, 2025 | 29.97 Mn |
| Jun 30, 2025 | 29.74 Mn |
| Mar 31, 2025 | 28.27 Mn |
| Dec 31, 2024 | 27.46 Mn |
| Sep 30, 2024 | 28.26 Mn |
| Dec 31, 2023 | 2.18 Mn |
| Dec 31, 2022 | 39.98 Mn |